GSDMD and atherosclerosis: DSF shows potential as a novel adjuvant therapy for atherosclerosis by concurrently modulating multiple atheroprotective pathways, including the inhibition of GsdmD, reduction in inflammatory markers, induction of autophagy, enhancement of efferocytosis and phagocytosis, and beneficial modulation of gut microbiota [10].